Table 3.
Ding Early onset prostate cancer 2016 | WALLACE_PROSTATE_CANCER_RACE_UP | |||||
---|---|---|---|---|---|---|
ID_REF | hsa-miR-142-5p | hsa-miR-150-5p | hsa-miR-146b-3p | ID_REF | hsa-miR-142-5p | hsa-miR-150-5p |
ADAMTS1 | NS | NS | − 0.639 | ADAMDEC1 | 0.724 | 0.715 |
APOE | NS | NS | 0.648 | CCR7 | 0.695 | 0.680 |
C4A | NS | NS | 0.664 | CD28 | 0.668 | NS |
CCDC74B | NS | NS | − 0.694 | CD3D | NS | NS |
CCL19 | NS | NS | 0.660 | CD48 | 0.657 | NS |
CCR7 | 0.695 | 0.680 | 0.746 | CXCL9 | 0.677 | NS |
CD3D | NS | NS | 0.644 | DOCK10 | 0.681 | 0.693 |
CD3E | NS | 0.651 | 0.685 | GZMK | 0.707 | 0.709 |
CD3G | 0.684 | 0.684 | 0.644 | IDO1 | 0.657 | NS |
CD6 | 0.641 | 0.644 | NS | IL2RG | 0.723 | 0.712 |
CD84 | 0.654 | NS | 0.675 | IL7R | 0.647 | 0.663 |
COL2A1 | NS | NS | 0.658 | ITGB2 | 0.705 | 0.640 |
CP | NS | NS | 0.648 | ITK | 0.685 | 0.659 |
E2F2 | NS | NS | 0.681 | MMP9 | 0.640 | NS |
EOMES | 0.650 | NS | 0.673 | PLEK | 0.655 | NS |
ERG | NS | NS | 0.653 | PTPRC | 0.675 | 0.689 |
HIST1H2AI | NS | NS | 0.723 | |||
HIST1H2BM | NS | NS | 0.701 | |||
HLA-DMB | NS | NS | 0.705 | |||
IKZF1 | NS | NS | 0.716 | |||
IL7R | 0.647 | 0.663 | 0.702 | |||
ITK | 0.685 | 0.659 | 0.681 | |||
LEPREL1 | NS | NS | − 0.770 | |||
LTB | 0.639 | NS | 0.661 | |||
MMP7 | NS | NS | 0.687 | |||
MMP9 | 0.640 | NS | 0.650 | |||
PDE3B | NS | NS | 0.667 | |||
PLP1 | NS | NS | − 0.705 | |||
PTPRC | 0.675 | 0.689 | 0.687 | |||
PYHIN1 | 0.680 | 0.683 | 0.649 | |||
SERPINA3 | NS | NS | 0.709 | |||
SLAMF6 | 0.726 | 0.672 | 0.647 | |||
SLC35F1 | NS | NS | − 0.654 | |||
TMEM178 | NS | NS | 0.671 | |||
UBD | NS | NS | 0.767 |
Genes in bold are common genes between both pathways.